Satoshi Takagi

Dr. Satoshi Takagi

Veterinary Teaching Hospital, Graduate School of Veterinary Medicine, Hokkaido University, Sapporo, Japan
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2023 in Cancers
Verified
Journal Article
Open access
PDF file
TDTatsuya Deguchi
Tatsuya Deguchi
NMNaoya Maekawa
Naoya Maekawa
SKSatoru Konnai
Satoru Konnai
RORyo Owaki
Ryo Owaki
KHKenji Hosoya
Kenji Hosoya
KOKazuhiko OHASHI
Kazuhiko OHASHI
Although immune checkpoint inhibitors (ICIs), such as the anti-programmed death-ligand 1 (PD-L1) antibody, have been developed for the treatment of canine malignant melanoma, desirable clinical efficacies have not been achieved. Recent studies in humans have suggested that radiation therapy (RT) combined with ICIs induces robust systemic antitumour immunity in patients with cancer. This study retrospectively examined the therapeutic efficacy of combination therapy (hypofractionated RT and anti-PD-L1 antibody [c4G12]) in dogs with pulmonary metastatic oral malignant melanoma. The intrathoracic clinical benefit rate (CBR)/median overall survival (OS) in the no RT (n = 20, free from the effect of RT), previous RT (n = 9, received RT ≤8 weeks prior to the first c4G12 dose), and concurrent RT (n = 10, c4G12 therapy within ±1 week of the first RT fraction) groups were 10%/185 days, 55.6%/283.5 days (p < 0.05 vs. no RT group), and 20%/129 days (p > 0.05 vs. no RT group), respectively. The adverse events were considered to be tolerable in the combination therapy. Thus, hypofractionated RT before the initiation of c4G12 therapy can be an effective approach for enhancing the therapeutic efficacy of immunotherapy, with acceptable safety profiles. Further prospective clinical studies are required to confirm the findings of this study.

26 July 2024 in The Veterinary Journal
Verified
Journal Article
Closed access
AYA. Yamauchi
A. Yamauchi
ROR. Oshita
R. Oshita
AKA. Kudo
A. Kudo
MUM. Umezawa
M. Umezawa
RSR. Shimizu
R. Shimizu
STSatoshi Takagi
Satoshi Takagi

25 August 2023 in Veterinary Sciences
Verified
Journal Article
Open access
PDF file
AYAkinori Yamauchi
Akinori Yamauchi
SYSho Yoshimoto
Sho Yoshimoto
AKAyano Kudo
Ayano Kudo
STSatoshi Takagi
Satoshi Takagi
Immunosenescence is an age-related change in the immune system characterized by a reduction in naïve T-cells and an impaired proliferative capacity of CD8+ T-cells in older individuals. Recent research revealed the crucial impact of immunosenescence on the development and control of cancer, and aging is one of the causes that diminish the therapeutic efficacy of cancer immunotherapies targeting CD8+ T-cell activation. Despite dog cancer being defined as an age-related disease, there are few fundamental understandings regarding the relationship between aging and the canine immune system. Therefore, we aimed to elucidate the characteristics of immunosenescence in dogs and analyzed the effects of aging on the differentiation status and proliferation of canine CD8+ T cells using T-cell specific stimulation with anti-canine CD3/CD28 antibody-coated beads and interleukin-2. As a result, we found that older dogs have a lower proliferative capacity of CD8+ T-cells and a reduction in the naïve subset in their peripheral blood. Further analysis showed that older dogs had attenuated proliferation of the effector and central memory subsets. These results indicate the importance of maintaining less differentiated subsets to expand CD8+ T-cells in dogs and provide helpful insight into the development of dog immune therapies that require T-cell expansion ex vivo.

23 August 2025 in Scientific Reports
Verified
Journal Article
Open access
PDF file
AKAyano Kudo
Ayano Kudo
SKShintaro Kamo
Shintaro Kamo
AYAkinori Yamauchi
Akinori Yamauchi
SYSho Yoshimoto
Sho Yoshimoto
YHYuma Harada
Yuma Harada
STSatoshi Takagi
Satoshi Takagi
Cancer-associated fibroblasts (CAFs) are key components of the tumor microenvironment (TME) that modulate T cell immunity by secreting humoral factors and forming structural barriers. CAFs secrete the chemokine C-X-C motif chemokine ligand 12 (CXCL12), which binds to C-X-C chemokine receptor 4 (CXCR4) on T cells and induces chemotaxis. Transforming growth factor beta 1 (TGF-β1), another humoral factor secreted by CAFs, has been reported to regulate the CXCL12/CXCR4 axis; however, a direct association between them has not been demonstrated in human medicine or veterinary medicine. This study investigated the role of canine CAFs in T cell migration through the CXCL12/CXCR4 axis and the regulatory influence of TGF-β1. CXCL12 and CXCR4 were expressed in the tumor stroma and on T cells, respectively, in dogs with epithelial malignant tumors. Canine CAFs secreted higher levels of CXCL12 and TGF-β1 than normal fibroblasts, and CAF-derived TGF-β1 modulated both CXCL12 secretion by CAFs and CXCR4 expression on T cells. Furthermore, canine CAFs induced T cell migration through the CXCL12/CXCR4 axis. These findings indicate that CAFs may influence T cell migration through the CXCL12/CXCR4 axis under the regulation of TGF-β1 signaling, highlighting their potential role in shaping T cell dynamics within the TME.

25 June 2022 in Animals
Verified
Journal Article
Open access
PDF file
RORyo Oshita
Ryo Oshita
SKSakie Katayose
Sakie Katayose
EKEiichi Kanai
Eiichi Kanai
STSatoshi Takagi
Satoshi Takagi
The response to treatment of brachycephalic airway syndrome (BAS) varies among brachycephalic dog breeds. We hypothesized that variations in nasal structure are one of the factors responsible for this difference. To confirm this variation, we measured the ratio of the airway cross-sectional area to the total nasal cavity area (AA/NC) in three brachycephalic dog breeds. Head CT images of French bulldogs, shih tzus, and pugs were retrospectively collected. Four specific transverse planes were used to calculate AA/NC ratios. Fifty brachycephalic dogs were included in the study: French bulldogs (n = 20), shih tzus (n = 20), and pugs (n = 10). The AA/NC ratio of Shih Tzus was larger in the rostral nasal cavity and smaller toward the caudal area, whereas the other two breeds showed an inverse tendency. The results obtained from the current research indicate that the AA/NC ratio can be used to evaluate the structure of the nasal cavity. Moreover, analyzing the point with the smallest AA/NC ratio can be useful in quantifying nasal airway obstruction and the severity of BAS. These results will be useful in understanding the complexity of BAS pathophysiology and in the implementation of treatment.

1 January 2022 in Journal of Veterinary Medical Science
Verified
Journal Article
Open access
PDF file
AKAyano Kudo
Ayano Kudo
SYSho Yoshimoto
Sho Yoshimoto
HYHiromitsu Yoshida
Hiromitsu Yoshida
YIYusuke Izumi
Yusuke Izumi
STSatoshi Takagi
Satoshi Takagi
Cancer-associated fibroblasts (CAFs) play an essential role in tumor invasion and metastasis. In dogs, the biological features of CAFs have not been well characterized. The purpose of this study was to investigate differences in the biological activities of canine CAFs and normal fibroblasts (NFs), and their influence on the migration and invasion of cancer cells. Canine CAFs and NFs were harvested from surgically-resected malignant epithelial tumor tissues and skin tissues of dogs. A wound-healing assay was conducted to compare the migratory and invasive abilities of canine CAFs and NFs. The results of this study showed that canine CAFs have a greater migratory and invasive ability than NFs. To observe the indirect and direct interactions between fibroblasts and cancer cells, Boyden chamber assay and 3D co-culture with collagen gel were conducted. The number of migrated and infiltrated cancer cells co-cultured with canine CAFs was greater than that with NFs. In the 3D co-culture, cancer cells showed noteworthy proliferation on the surface of gels containing canine CAFs and invasion into the gel. On the other hand, no infiltration of cancer cells into the gel containing NFs was observed. It was suggested that canine CAFs activate migration and invasion of cancer cells and promote the infiltration of cancer cells into collagen gels.